首页> 外文期刊>Brain research >Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
【24h】

Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.

机译:小鼠吗啡痛觉过敏与阿片类药物的活性,镇痛或耐受性无关:多种多样的痛觉过敏系统的证据。

获取原文
获取原文并翻译 | 示例
           

摘要

Hyperalgesia following chronic morphine treatment is thought to be a response to opioid receptor activation and analgesia and contribute to the development of analgesic tolerance. Here, the relationship between these variables was studied in mice tested for nociceptive sensitivity on the tail-withdrawal test during chronic infusion of various morphine doses. Hyperalgesic onset was preceded by dose-dependent analgesia except for the lowest morphine dose, which caused hyperalgesia 6 h after the start of infusion. Morphine ED50 values obtained at various infusion intervals demonstrated both analgesic tolerance in the absence of hyperalgesia and hyperalgesia in the absence of tolerance. Continuous opioid receptor antagonism using naltrexone pellets abolished analgesia during continuous morphine administration, transiently potentiated hyperalgesia, and revealed differences in hyperalgesic onset between morphine infusion doses. Acute injection of the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 attenuated hyperalgesia in naltrexone-treated mice, demonstrating a role for this receptor in morphine hyperalgesia unrelated to its effects upon morphine analgesia. In mice where hyperalgesia subsided after continuous infusion of the highest morphine dose (i.e., hyperalgesic adaptation), hyperalgesia was restored after infusing the lower but not higher morphine dose. In addition, acute injection of morphine-3beta-glucoronide (M3G) caused hyperalgesia that was cross-adaptive with the lower morphine dose only. The data demonstrate that morphine hyperalgesia is independent of prior or concurrent opioid receptor activity or analgesia and is unrelated to analgesic tolerance. Furthermore, the lack of hyperalgesic cross-adaptation between high and low morphine doses, and their differential cross-adaptation with M3G hyperalgesia, also suggests distinct morphine dose-dependent hyperalgesic systems.
机译:慢性吗啡治疗后的痛觉过敏被认为是对阿片样物质受体激活和镇痛的反应,并有助于镇痛耐受性的发展。在这里,在长期输注不同剂量吗啡剂量的小鼠的尾部撤回试验中,对这些变量之间的伤害感受敏感性进行了测试,研究了这些变量之间的关系。除最低吗啡剂量外,在开始输注后6 h会引起痛觉过敏,除此以外,吗啡起先于剂量依赖性镇痛。在不同输注间隔获得的吗啡ED50值在无痛觉过敏的情况下显示出镇痛耐受性,在无耐受性的情况下显示出痛觉过敏。使用纳曲酮药丸进行的持续阿片样物质受体拮抗作用在连续吗啡给药期间消除了镇痛作用,短暂地增强了痛觉过敏,并揭示了吗啡输注剂量之间痛觉过敏发作的差异。 N-甲基-D-天门冬氨酸(NMDA)受体拮抗剂MK-801的急性注射减轻了纳曲酮治疗小鼠的痛觉过敏,表明该受体在吗啡痛觉过敏中的作用与其对吗啡镇痛的作用无关。在连续注入最高剂量的吗啡后痛觉过敏消失的小鼠(即痛觉过敏适应性),在注入较低但不是较高的吗啡剂量后痛觉过敏得以恢复。此外,急性注射吗啡3β-葡糖苷酸(M3G)引起的痛觉过敏仅与较低的吗啡剂量具有交叉适应性。数据表明吗啡痛觉过敏与先前或同时存在的阿片受体活性或镇痛无关,并且与镇痛耐受性无关。此外,在高剂量和低剂量吗啡之间缺乏痛觉过敏交叉适应,以及它们与M3G痛觉过敏的差异性交叉适应,也表明了独特的吗啡剂量依赖性痛觉过敏系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号